People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,704.95INR
6:18am EDT
Price Change (% chg)

Rs53.05 (+2.00%)
Prev Close
Rs2,651.90
Open
Rs2,652.00
Day's High
Rs2,727.05
Day's Low
Rs2,620.15
Volume
25,227
Avg. Vol
35,640
52-wk High
Rs2,939.80
52-wk Low
Rs2,025.00

Search Stocks

Chari, Raghav 

Brief Biography

Dr. Raghav Chari is Senior Vice President - Proprietary Products of Dr Reddys Laboratories Ltd. He heads Proprietary Products segment and is responsible for developing a viable portfolio of products across Company's New Chemical Entities and Differentiated Formulations businesses. Dr. Chari joined the Company in 2006 as Vice President- Corporate Development for Company's New Chemical Entities and Specialty business and has helped shape Company's Proprietary Products business strategy while developing alliance platforms. He started his career with McKinsey and Company, where he spent several years as an Associate, Engagement Manager and finally Associate Principal in McKinsey’s Pharmaceuticals and Medical Products practice. After McKinsey, he took leadership roles in strategy and business development with several smaller biotech companies. Prior to joining the Company, he was the head of the Corporate Strategy function at NPS Pharmaceuticals. Dr. Chari is a graduate in Mathematics and Physics from the California Institute of Technology and holds a Ph.D in Theoretical Physics from Princeton University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

G. Prasad

80,830,000

Satish Reddy

79,653,000

Sripada Chandrasekhar

--

Saumen Chakraborty

15,000,000

R. Ananthanarayanan

--

Abhijit Mukherjee

14,600,000
As Of 30 Mar 2013
Search Stocks